PAEDIATRICS, KAVLI & DPAG SPECIAL LECTURE: Bespoke CRISPR Gene Editing Therapies at Nationwide Scale: an Actionable Path
SPEAKER BIOGRAPHY

Fyodor Urnov is the Director for Technology and Translation at the Innovative Genomics Institute and a Professor of Molecular Therapeutics in the Department of Molecular and Cell Biology at UC Berkeley. He co-developed the toolbox of human genome and epigenome editing, co-named genome editing, and was on the team that advanced all of its first-in-human applications to the clinic. He also led the effort that identified the genome editing target for an approved medicine to treat sickle cell disease and beta-thalassemia. A major goal for the field of genome editing and a key focus of Fyodor’s work is expanding access to CRISPR therapies for genetic disease. As part of that effort Fyodor directs the Danaher-IGI Beacon for CRISPR Cures – a first-in-class academia-industry partnership developing and advancing to the clinic scalable CRISPR-based approaches to treat diseases of the immune system. Fyodor also leads cross-functional teams in developing and advancing to the clinic CRISPR-based approaches to treat neurodegenerative, neuroinflammatory, and infectious diseases.
Date: 7 July 2025, 16:00
Venue: Sherrington Building, off Parks Road OX1 3PT
Venue Details: Blakemore Lecture Theatre
Speaker: Professor Fyodor Urnov (University of California, Berkeley)
Organising department: Department of Physiology, Anatomy and Genetics (DPAG)
Organiser: Professor Matthew Wood (University of Oxford)
Organiser contact email address: events@dpag.ox.ac.uk
Host: Professor Matthew Wood (University of Oxford)
Part of: DPAG Prize Lectures
Booking required?: Not required
Audience: Members of the University only
Editor: Hannah Simm